My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
2023-140
CBCC
>
Official Documents
>
2020's
>
2023
>
2023-140
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/4/2023 12:08:17 PM
Creation date
8/4/2023 12:06:37 PM
Metadata
Fields
Template:
Official Documents
Official Document Type
Agreement
Approved Date
07/11/2023
Control Number
2023-140
Agenda Item Number
8.T.
Entity Name
RxBenefits. Inc. f/k/a Prescription Benefits, Inc
Subject
Addendum to Administrative Service Agreement reflecting improved pricing
and updates effective January1, 2023
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
23
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
DocuSign Envelope ID: 5332467E-CBEF4C5D-8BOE-61 E380BDAI I B <br />DocuSign Envelope ID: 151 ECOCF-B55C-414F-9455-72004347A31 0 <br />(1/2023 Version) <br />fees, in a cash transaction on the date the vaccine is dispensed as reported to PBM by the <br />Participating Pharmacy. <br />4. The Vaccine Administration Fee for Vaccine Claims for Members enrolled in Client's <br />Medicaid programs, if any, will be capped at the maximum reimbursable amount under the <br />state Medicaid program in which the Member is enrolled. <br />5. All Vaccine Claims will be subject to any Transaction Fees set forth in the Agreement. <br />6. Vaccine Claims will be charged a program fee of $2.50 per Vaccine Claim (except for <br />Medicare Part D covered Vaccine Claims, if applicable). The Vaccine Program Fee will <br />be billed separately to Client as part of the administrative invoice according to the billing <br />frequency set forth in this Agreement. <br />(b) Commercial (Including Medicaid and Exchange, if applicable) <br />(c) Medicare Part D Covered Vaccine Claims: Medicare Part D Vaccine Claims shall adjudicate at the <br />lower of U&C or the amounts shown in the table below. <br />16 <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />Participating Pharmacy <br />Member Submitted <br />Pharmacy <br />INFLUENZA <br />Pass -Through <br />OTHERParticipating <br />ALL <br />VACCINES <br />Pass -Through <br />(excluding foreign claims) <br />Vaccine <br />Administration <br />(capped(capped <br />at <br />at $20 per <br />Fee <br />vper <br />vaccine <br />vaccine cll aim) <br />vaccine claim and $40 <br />Submitted amount <br />per covid vaccine claim <br />Ingredient Cost <br />Participating Pharmacy <br />Participating Pharmacy <br />Ingredient Cost as set <br />Ingredient Cost as set <br />Submitted amount <br />forth in the Agreement <br />forth in the Agreement <br />Dispensing Fee <br />Participating Pharmacy <br />Participating Pharmacy <br />Dispensinge as set <br />Dispensing Fee as set <br />Submitted amount <br />forth in the�A,reernent <br />forth in the Agreement <br />Administrative <br />Administrative Fee per Prescription Drug Claim as <br />Administrative Fee per <br />Fee/Vaccine <br />set forth in the Agreement <br />Prescription Drug Claim <br />Claim <br />(plus manual claim <br />administrative fee) as set <br />forth in the Agreement <br />Vaccine Program <br />$2.50 per vaccine claim <br />N/A <br />Fee <br />(c) Medicare Part D Covered Vaccine Claims: Medicare Part D Vaccine Claims shall adjudicate at the <br />lower of U&C or the amounts shown in the table below. <br />16 <br />NOT FOR DISTRIBUTION. THE INFORMATION CONTAINED HEREIN IS CONFIDENTIAL, PROPRIETARY <br />AND CONSTITUTES TRADE SECRETS OF ESI AND RXBENEFITS <br />
The URL can be used to link to this page
Your browser does not support the video tag.